Advertisement

Quintiles Company Profile

02:25 EDT 21st May 2013 | BioPortfolio

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more than 20,000 engaged professionals in 60 countries works with an unwavering commitment to patients, safety and ethics. Quintiles helps biopharmaceutical companies navigate risk and seize opportunities in an environment where change is constant. For more information, please visit www.quintiles.com.

Location

4709 CREEKSTONE DRIVE, SUITE 200
Durham
NC
27703-8411
United States of America

Contact

Phone: 919 998 2000


News Articles [ 209 Associated News Articles listed on BioPortfolio]

Quintiles raises $525 million in IPO

Quintiles Transnational Corp. (NYSE:Q) raised $525 million through the sale of 13.1 million shares at $40 in an IPO on Wednesday. The price -- at the high-end of Quintiles' proposed $36-$40 range -- v...

Quintiles releases new reporting and analytics solution

Quintiles has released Quintiles Infosario solution, an interactive, role-based navigation as part of its next generation of Quintiles Infosario Reporting & Analytics Platform.

Quintiles files for $600M IPO

CRO Quintiles Transnational Corp. (Research Triangle Park, N.C.) proposed to raise up to $600 million in an IPO underwritten by Morgan Stanley; Barclays; JPMorgan; and 10 other banks. Quintiles report...

BMS biopharma partners with Quintiles for central lab services

Bristol-Myers Squibb, a big pharma company, biopharma partners with Quintiles, selecting the CRO giant to handle global central lab services for its pipeline treatments. The 5-year partnering deal als...

Quintiles looking for an IPO

Quintiles Transnational Corp, the largest provider of contract research for the pharmaceutical and biotechnology industries, is speaking to banksabout a potential initial public offering, two peopl...

Would you invest in a public Quintiles?

Rumours of a Quintiles IPO will not go away but as yet nothing has been confirmed. 

Quintiles prices IPO at $40 per share

Quintiles has announced the pricing of its initial public offering of 23,684,210 shares of its common stock at a price to the public of $40.00 per share. The shares of Quintiles common stock are expec...

Quintiles Seeks to Raise as Much as $790M in IPO Next Month

CRO Quintiles and its shareholders are offering more than 19 million shares of common stock that will be priced between $36 and $40 per share, according to an updated S-1 filing with the US SEC .

Drugs and Medications [0 Results]

None

PubMed Articles [ 35 Associated PubMed Articles listed on BioPortfolio]

The Neurobiology of Erythropoietin.

Discussion on the paper 'Prediction of accrual closure date in multi-center clinical trials with discrete-time Poisson process models', by Gong Tang, Yuan Kong, Chung-Chou Ho Chang, Lan Kong, and Joseph P. Costantino.

Household Expenditures for Medicines and the Role of Free Medicines in the Brazilian Public Health System.

Objectives. We sought to investigate, across different socioeconomic groups, the proportion of household medicine expenses that were paid by households and the proportion paid by the Brazilian nationa...

Adaptive design methods in clinical trials, second edition, by s.-C. Chow and m. Chang.

Examining catastrophic health expenditures at variable thresholds using household consumption expenditure diaries.

Objective  Using uniform thresholds and a set of variable threshold levels, this study examined the incidence of catastrophe amongst households of different socio-economic status (SES) quintiles. Me...

Clinical Trials [ 2 Associated Clinical Trials listed on BioPortfolio]

A Study to Assess the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Multiple Ascending Doses of AZD5069 in Healthy Volunteers

The purpose of this study is to explore the safety and tolerability of AZD5069 at steady-state, following twice a day oral dosing in healthy subjects. AZD5069 is being developed by AstraZ...

Experimental Vaccine for Plasmodium Falciparum Malaria

This study will evaluate the safety of two experimental malaria vaccines in healthy volunteers and examine their immune response to them. Safety will be assessed by comparing vaccine side...

Companies [ 14 Associated Companies listed on BioPortfolio]

Quintiles

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of mo...

Quintiles Transnational Holdings Inc.

Quintiles is the only fully integrated biopharmaceutical services company offering clinical, commercial, consulting and capital solutions worldwide. The Quintiles network of more...

Quintiles Pacific Inc.

Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare...

Quintiles Transnational Corporation

Quintiles Transnational is the world's leading provider of information, technology and services to bring new medicines to patients faster and improve healthcare. Founded in 1982 and headquartered near...

Quintiles Transnational Corp.

Quintiles Transnational helps improve healthcare worldwide by providing a broad range of professional services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare...

More Information about "Quintiles" on BioPortfolio

We have published hundreds of Quintiles news stories on BioPortfolio along with dozens of Quintiles Clinical Trials and PubMed Articles about Quintiles for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Quintiles Companies in our database. You can also find out about relevant Quintiles Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement